利索-全球专利检索

  1. 登录
  2. 注册
发明授权
US10471083B2 Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis 有权

  • 专利标题： Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
  • 申请号： US14232546
    申请日： 2012-07-12
  • 公开(公告)号： US10471083B2
    公开(公告)日： 2019-11-12
  • 发明人: Alan Bruce Montgomery
  • 申请人： Alan Bruce Montgomery
  • 申请人地址： US TX Austin
  • 专利权人： SAVARA INC.
  • 当前专利权人： SAVARA INC.
  • 当前专利权人地址： US TX Austin
  • 代理机构： VLP Law Group, LLP
  • 代理商 Kurt T. Mulville
  • 国际申请： PCT/US2012/046559 WO 20120712
  • 国际公布： WO2013/010041 WO 20130117
  • 主分类号： A61K31/7036
  • IPC分类号： A61K31/7036 ;  A61K31/665 ;  A61K9/00
Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
摘要：
The present invention is antibiotic compositions, ventilator based systems and methods relating to ventilator-associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis. Antibiotic combinations of fosfomycin and an aminoglycoside, preferably amikacin, are administered via an in-line nebulizer within the airway of the ventilator. Humidified conditions create an improved aerosol mist to treat VAP and VAT.
公开/授权文献
信息查询
Espacenet
0/0